Company / SG&A per Share
Intellia Therapeutics, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.17
FY2025
5-year range
$1.07 / $1.35
FY2021-FY2025
Trend
-13.2%
vs FY2024
Sector context
#127 of 150
Health Care
What the data says
Intellia Therapeutics, Inc.'s sg&a per share of $1.17 is lower than 85% of companies in the Health Care sector (FY2025). SG&A per Share has fluctuated over the past 10 years, ranging from $0.76 in FY2016 to $1.35 in FY2024.
Based on SEC 10-K filings.
1.17 in FY2025 with a 5-year CAGR of +5.9%.
Improved from $1.34 to $1.17 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -1.1%
- 5-Year CAGR
- +5.9%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 150This company $1.17 Sector average $11878.17
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 13.2% year-over-year.
- Ranks #127 out of 150 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2024.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.17 | -13.2% |
| FY2024 | $1.35 | +1.2% |
| FY2023 | $1.34 | +10.3% |
| FY2022 | $1.21 | +12.9% |
| FY2021 | $1.07 | +22.0% |
| FY2020 | $0.88 | -3.1% |
| FY2019 | $0.91 | +19.5% |
| FY2018 | $0.76 | -2.4% |
| FY2017 | $0.78 | +3.0% |
| FY2016 | $0.76 | -97.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026